Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C.
about
Differential liver protein expression during schistosomiasis.New multi protein patterns differentiate liver fibrosis stages and hepatocellular carcinoma in chronic hepatitis C serum samples.Protein profile of human hepatocarcinoma cell line SMMC-7721: identification and functional analysisOncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.Detection and identification of NAP-2 as a biomarker in hepatitis B-related hepatocellular carcinoma by proteomic approach.Proteomic expression signature distinguishes cancerous and nonmalignant tissues in hepatocellular carcinoma.A pilot study of proteomic profiles of human hepatocellular carcinoma in the United States.Proteomic analysis of differentially expressed proteins in hepatitis B virus-related hepatocellular carcinoma tissuesDifferential patterns of liver proteins in experimental murine hepatosplenic schistosomiasis.Contribution of laser microdissection-based technology to proteomic analysis in hepatocellular carcinoma developing on cirrhosis.Adenosine triphosphatase pontin is overexpressed in hepatocellular carcinoma and coregulated with reptin through a new posttranslational mechanism.Identification of serum CCL15 in hepatocellular carcinoma.The current state of proteomics in GI oncology.Proteomic differences between hepatocellular carcinoma and nontumorous liver tissue investigated by a combined gel-based and label-free quantitative proteomics study.Proteome mapping of epidermal growth factor induced hepatocellular carcinomas identifies novel cell metabolism targets and mitogen activated protein kinase signalling events.Hep88 mAb-initiated paraptosis-like PCD pathway in hepatocellular carcinoma cell line through the binding of mortalin (HSPA9) and alpha-enolase.Capturing and identification of differentially expressed fucome by a gel free and label free approach.A possible predictive marker of progression for hepatocellular carcinomaAssociation between apolipoprotein E genotype, chronic liver disease, and hepatitis B virus.High-dimensional biology to comprehend hepatocellular carcinoma.A systems biology approach for understanding the collagen regulatory network in alcoholic liver disease.Proteomic analysis of schistosomiasis japonica vaccine candidate antigens recognized by UV-attenuated cercariae-immunized porcine serum IgG2.Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells.The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.Identification of CD14 as a potential biomarker of hepatocellular carcinoma using iTRAQ quantitative proteomics.Matrix metalloproteinase 3 is present in the cell nucleus and is involved in apoptosis.Reptin regulates insulin-stimulated Akt phosphorylation in hepatocellular carcinoma via the regulation of SHP-1/PTPN6.
P2860
Q33263474-38BBE149-A7F2-468B-8651-3AAD9A440DB0Q33266698-9C863C58-3F2F-4A4D-9821-4FF66F753223Q33286842-2C36043D-88AA-4A41-85FC-DB2D1F072567Q33298434-DBF2EA85-960B-421B-874C-389D5E47A860Q33302500-17C6485F-5996-4269-A36A-201E600D5A95Q33323235-01D4A9B9-A756-4460-9E37-FC8D00DE9C4DQ33401908-554AF623-FC3F-4D0A-84CA-FEC69536F644Q33470083-DAE55AE4-EBEE-412E-A1D2-875004AADF22Q33498165-1E212F6F-5C36-4CBA-9ADA-4E1DA7FE771FQ33613931-17468DCF-8B60-4EAB-886F-BB97897E0C00Q33764377-99993F19-8025-4FAD-A8A2-1A789F60C6F1Q34080748-7AD2E102-FCBC-4BB2-9342-2EEA2F38D7E7Q34549009-4385BE2B-558A-48BF-AFEF-51C8A76ABFA7Q34608851-756D8A17-64CA-4296-9373-8177A58FA3F7Q34609315-E9FC3330-4474-4036-BB1E-00621E7A3107Q35170154-109991A5-A414-4F4B-B77E-8590BE527D76Q35189366-2831CB70-528D-4A1C-8E78-9EC1D5E46C0BQ35268866-AF9708E0-C954-4E9E-B779-DE184141C28BQ36121445-28580A9D-24D7-4020-ACA7-5DB68784BE11Q36306703-825534F1-113C-4939-BB9E-C70B150DD36CQ37087376-5DD13EE1-4EA0-455E-AF2F-20FC3655797BQ37899945-D351A575-82B4-44CA-A677-60EDD587D5E1Q38489789-631CDC07-48F3-417F-BA43-A9B1A458C669Q39154317-AF70EC99-0E5E-4E21-A9F7-47D55FE117D6Q39195622-60BDC0AC-CEF3-4A58-8F57-0FAC58CA23B7Q41924403-B6229E0E-4B88-4871-A208-573A531F82B8Q42988559-C0CA1039-A881-4177-9EDD-40318AA2C2BDQ47916536-B17213F3-958A-4E6E-B223-F9D15C7588E8
P2860
Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Proteomic analysis of differen ...... ith chronic viral hepatitis C.
@ast
Proteomic analysis of differen ...... ith chronic viral hepatitis C.
@en
type
label
Proteomic analysis of differen ...... ith chronic viral hepatitis C.
@ast
Proteomic analysis of differen ...... ith chronic viral hepatitis C.
@en
prefLabel
Proteomic analysis of differen ...... ith chronic viral hepatitis C.
@ast
Proteomic analysis of differen ...... ith chronic viral hepatitis C.
@en
P2093
P50
P356
P1433
P1476
Proteomic analysis of differen ...... ith chronic viral hepatitis C.
@en
P2093
Charles Balabaud
Jean-Frédéric Blanc
Jean-Marc Gion
Jean-Marie Schmitter
Katell Bathany
Marc Bonneu
P304
P356
10.1002/PMIC.200401194
P577
2005-09-01T00:00:00Z